Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study

Author:

Cheng Kai-Hung12ORCID,Cheng Kai-Chun345,Cheng Kai-Yuan6,Yang Yi-Hsin7,Lee Chung-Wei89,Lai Wen-Ter10

Affiliation:

1. Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;

2. Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;

3. Department of Ophthalmology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;

4. Department of Ophthalmology, Kaohsiung Municipal Hsiao-kang Hospital, Kaohsiung, Taiwan;

5. Department of Optometry, Shu-Zen Junior College of Medicine and Management, Kaohsiung, Taiwan

6. Department of Otolaryngology, Head and Neck Surgery, Ministry of Health and Welfare Pingtung Hospital, Pingtung, Taiwan;

7. School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan;

8. Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA;

9. Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA;

10. Department of Internal Medicine, Kaohsiung Municipal United Hospital, Kaohsiung, Taiwan;

Publisher

Informa UK Limited

Subject

General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. New Insights into the Nephroprotective Potential of Lercanidipine;International Journal of Molecular Sciences;2023-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3